Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Use of Meropenem and Other Antimicrobial Lock Therapy in the Treatment of Catheter-Related Blood Stream Infections in Neonates

A Retrospective Study

Bibliographic Data

ID15719129
AuthorsFiammetta Piersigilli (0000-0002-6581-2822, UCLouvain, corresponding author), Cinzia Auriti (0000-0001-9820-6557, Bambino Gesù Children's Hospital), Andrea Dotta (0000-0002-1260-6427, Bambino Gesù Children's Hospital), Bianca Maria Goffredo (0000-0001-9933-3240, Bambino Gesù Children's Hospital), Sara Cairoli (0000-0002-5925-0974, Bambino Gesù Children's Hospital), Immacolata Savarese (Bambino Gesù Children's Hospital), Francesca Campi (Bambino Gesù Children's Hospital), Tiziana Corsetti (Bambino Gesù Children's Hospital), Iliana Bersani (0000-0002-3020-2274, Bambino Gesù Children's Hospital)
Year2022
Volume9
Issue5
Pages614-614
Publication date2022-04-26
Open AccessYes
TypeARTICLE
VenueChildren (JOURNAL)
Journal identifiersISSN: 2227-9067 • E-ISSN: 2227-9067
PublisherMultidisciplinary Digital Publishing Institute (PUBLISHER • CH)
DOI10.3390/children9050614
PMID35626791
OpenAlexW4224998231
LanguageEN
References cited33

(1) Background: Newborns admitted to Neonatal Intensive Care Units (NICUs) often require the placement of central vascular catheters (CVC), which are a major risk factor for hospital infection. Numerous strategies exist to prevent central line-associated blood stream infections (CLABSIs) and catheter-related bloodstream infections (CRBSIs), with only a few offering options to save the catheter when it is impossible to replace. CRBSIs continue to be a major problem for neonates in NICUs. Most CRBSIs are resistant to systemic antibiotics due to the presence of intraluminal bacterial biofilm. Therefore, catheter removal is frequently necessary when a CRBSI occurs. The so-called Antibiotic Lock Therapy (ALT) is an antimicrobial therapeutic strategy which seems to be promising in neonates when catheter removal is difficult due to critical conditions. To date, evidence about the use of ALT in the neonatal period is still fragmentary, since only poor and heterogeneous data exist. (2) Methods: We report our successful experience with ALT in seriously ill neonates with CRBSI for whom the replacement of the catheter could have been life threatening. (3) Results: ALT repetitively performed for at least 12 h was effective in 11 out of 13 infants (84.6%). It was not effective in two infants in whom ALT was performed for only 6 h. Moreover, we present new data about the stability testing of meropenem for its use during ALT in neonates. (4) Conclusions: When CRBSI occurs-bearing in mind that the optimal management is catheter removal if antibiotic therapy is not effective within 48 h-ALT seems to be a valid alternative therapy when removal is impractical due to critical conditions

Antibiotic resistance · Antibiotics · Antimicrobial · Blood culture · Blood stream · Catheter · Central line · Intensive care · Intensive care medicine · Meropenem · Retrospective cohort study · Antibiotics Pharmacokinetics and Efficacy · Central Venous Catheters and Hemodialysis · Medicine · Streptococcal Infections and Treatments · Internal Medicine · Surgery

Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae